| Case Report | Korean J Pain 2010 December; Vol. 23, No. 4: 266-269 pISSN 2005-9159 eISSN 2093-0569 DOI：10.3344/kjp.2010.23.4.266 Pregnancy in Woman with Spinal Cord Stimulator for Complex Regional Pain Syndrome: A Case Report and Review of the Literature Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, *Kyung Hee University East-West Neo Medical Center, Seoul, †Chungbuk National University Hospital, Cheongju, Korea † Hyung Seok Yoo, MD, Francis Sahngun Nahm, MD, Kyoung Hoon Yim, MD , Jee Youn Moon, MD*, and Yung Suk Kim, MD*, and Pyung Bok Lee, MD Spinal cord stimulation (SCS) is used to manage chronic pain syndromes and it is accepted a cost-effective therapy. Child-bearing women who had SCS become or choose to become pregnant despite these policies pregnancy is a relative contraindication. A 32-year-old woman had SCS as a treatment for the CRPS I of the left lower extremity. During various check up tests, we happen to find out that her serum beta-hCG was positive and confirmed pregnancy. SCS is not recommended in pregnancy because the effects of SCS on pregnancy and nursing mothers had not been confirmed. However, many female patients suffering from chronic pain may expect future pregnancy and we think that they must be informed about the possibility of pregnancy and the effects of SCS device implantation in the course of pregnancy. First of all, a good outcome requires a multidisciplinary team approach, including obstetrics, neonatology, pain medicine and anesthesia, as was used from an early pregnancy. Unfortunately, she had a misabortrion after 6 weeks. (Korean J Pain 2010; 23: 266-269) Key Words: labor, pregnancy, spinal cord stimulation. Spinal cord stimulation (SCS) is becoming an increas- ingly popular method for the treatment of chronic pain syndromes, including diabetic neuropathy, failed back sur- gery syndrome, complex regional pain syndrome, chronic arachnoiditis, phantom limb pain, ischemic limb pain, re- fractory unilateral limb pain syndrome, angina, post- herpetic neuralgia and acute herpes zoster pain. The goal of the treatment is not a cure, but a therapeutic option that can significantly reduce pain and improve the quality of life for most patients. In addition, SCS has been proved to reduce the typical medication dose needed [1,2]. It is now widely used for a number of indications (over 14,000 SCS implantations occur annually world-wide [3]). Given the annual SCS implantation growth rate, SCS is likely to be Received September 27, 2010. Revised November 8, 2010. Accepted November 9, 2010. Correspondence to: Pyung Bok Lee, MD Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 166, Gumi-ro, Bundang-gu, Seongnam 463-707, Korea Tel: ＋82-31-787-7495, Fax: ＋82-31-787-4063, E-mail: painfree@shubh.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ⓒ The Korean Pain Society, 2010